Adrenomedullin and endothelin-1 are related to inflammation in chronic heart failure

Inflammation Research

Volumn 58, Issue 6, 2009, Pages 298-305

  Gombos, T ^a   Forhecz Z ^a   Pozsonyi, Z ^a   Wallentin, S ^a   Papassotiriou, J ^c   Kunde, J ^c   Morgenthaler, N G ^c   Janoskuti L ^a   Prohaszka Z ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c BRAHMS Aktiengesellschaft ^*  (Germany)

Author keywords

Adrenomedullin; Endothelin 1; Heart failure; Inflammation

Indexed keywords

ACETYLSALICYLIC ACID; ADRENOMEDULLIN; ALBUMIN; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; ION; LOOP DIURETIC AGENT; NITRATE; SERUM ALBUMIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; WATER;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOMEOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; PROTEIN BLOOD LEVEL; SANDWICH IMMUNOLUMINOMETRIC ASSAY;

ADRENOMEDULLIN; AGED; BIOLOGICAL MARKERS; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; ENDOTHELIN-1; FEMALE; HEART FAILURE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; VENTRICULAR DYSFUNCTION, LEFT;

EID: 67649548461     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-008-8184-5     Document Type: Article

References (36)

1. McMurray JJ and Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart 2000;83:596- 602.
2. Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R and Mann DL. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 1995;92:1487-93.
3. Anker SD and von Haehling S. Inflammatory mediators in chronic heart failure: an overview. Heart 2004;90:464-70.
4. Anker SD, Egerer KR, Volk HD, Kox WJ, Poole-Wilson PA and Coats AJ. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol 1997;79:1426-30.
5. Sandek A, Bauditz J, Swidsinski A, Buhner S, Weber-Eibel J, von Haehling S et al. Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol 2007;50:1561-9.
6. Yndestad A, Damas JK, Oie E, Ueland T, Gullestad L and Au-krust P. Role of inflammation in the progression of heart failure. Curr Cardiol Rep 2007;9:236-41.
7. Jankowska EA, Ponikowski P, Piepoli MF, Banasiak W, Anker SD and Poole-Wilson PA. Autonomic imbalance and immune activation in chronic heart failure - pathophysiological links. Car-diovasc Res 2006;70:434-45.
8. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993;192:553-60.
9. Ishimitsu T, Ono H, Minami J and Matsuoka H. Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders. Pharmacol Ther 2006;111:909-27.
10. Eto T, Kato J and Kitamura K. Regulation of production and secretion of adrenomedullin in the cardiovascular system. Regul Pept 2003;112:61-9.
11. Yanagawa B and Nagaya N. Adrenomedullin: molecular mechanisms and its role in cardiac disease. Amino Acids 2007;32:157-64.
12. Khan SQ, O'Brien RJ, Struck J, Quinn P, Morgenthaler N, Squire I et al. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol 2007;49:1525-32.
13. Gegenhuber A, Struck J, Dieplinger B, Poelz W, Pacher R, Morgenthaler NG et al. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure. J Card Fail 2007;13:42-9.
14. Masaki T. Possible role of endothelin in endothelial regulation of vascular tone. Annual review of pharmacology and toxicology 1995;35:235-55.
15. Brunner F, Bras-Silva C, Cerdeira AS and Leite-Moreira AF Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacology & therapeutics 2006;111:508-31.
16. Yang LL, Arab S, Liu P, Stewart DJ and Husain M. The role of endothelin-1 in myocarditis and inflammatory cardiomyopathy: old lessons and new insights. Can J Physiol Pharmacol 2005;83:47-62.
17. Sharma R, Coats AJ and Anker SD. The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1. Int J Cardiol 2000;72:175-86.
18. Cowburn PJ and Cleland JG. Endothelin antagonists for chronic heart failure: do they have a role? Eur Heart J 2001;22:1772-84.
19. Kelland NF and Webb DJ. Clinical trials of endothelin antagonists in heart failure: a question of dose? Exp Biol Med (Maywood) 2006;231:696-9.
20. Kelland NF and Webb DJ. Clinical trials of endothelin antagonists in heart failure: publication is good for the public health. Heart 2007;93:2-4.
21. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M et al. [Guidelines for the Diagnosis and Treatment of Chronic Heart Failure: executive summary (update 2005)]. Rev Esp Cardiol 2005;58:1062-92.
22. Morgenthaler NG, Struck J, Alonso C and Bergmann A. Measurement of midregional proadrenomedullin in plasma with an im-munoluminometric assay. Clin Chem 2005;51:1823-9.
23. Papassotiriou J, Morgenthaler NG, Struck J, Alonso C and Bergmann A. Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma. Clin Chem 2006;52:1144-51.
24. Nicholls MG, Charles CJ, Lainchbury JG, Lewis LK, Rademaker MT, Richards AM et al. Adrenomedullin in heart failure. Hypertens Res 2003;26 Suppl:S135-40.
25. Wei CM, Lerman A, Rodeheffer RJ, McGregor CG, Brandt RR, Wright S et al. Endothelin in human congestive heart failure. Circulation 1994;89:1580-6.
26. Zudaire E, Portal-Nunez S and Cuttitta F The central role of adrenomedullin in host defense. J Leukoc Biol 2006;80:237-44.
27. Suzuki Y, Horio T, Hayashi T, Nonogi H, Kitamura K, Eto Tet al. Plasma adrenomedullin concentration is increased in patients with peripheral arterial occlusive disease associated with vascular inflammation. Regul Pept 2004;118:99-104.
28. Suzuki Y, Horio T, Nonogi H, Hayashi T, Kitamura K, Eto Tet al. Adrenomedullin as a sensitive marker for coronary and peripheral arterial complications in patients with atherosclerotic risks. Peptides 2004;25:1321-6.
29. Genesca J, Gonzalez A, Catalan R, Segura R, Martinez M, Esteban R et al. Adrenomedullin, a vasodilator peptide implicated in hemodynamic alterations of liver cirrhosis: relationship to nitric oxide. Dig Dis Sci 1999;44:372-6.
30. Fujioka S. Increased plasma concentration of adrenomedullin during and after major surgery. Surg Today 2001;31:575 -9.
31. Piechota M, Banach M, Irzmanski R, Barylski M, Piechota-Ur-banska M, Kowalski J et al. Plasma endothelin-1 levels in septic patients. J Intensive Care Med 2007;22:232-9.
32. Koller-Strametz J, Pacher R, Frey B, Kos T, Woloszczuk W and Stanek B. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables. J Heart Lung Transplant 1998;17:356- 62.
33. Yang LL, Gros R, Kabir MG, Sadi A, Gotlieb AI, Husain M et al. Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice. Circulation 2004;109:255-61.
34. Nozaki N, Yamaguchi S, Shirakabe M, Nakamura H and Tomoike H. Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure. Jpn Circ J 1997;61:657-64.
35. Niethammer M, Sieber M, von Haehling S, Anker SD, Munzel T, Horstick G et al. Inflammatory pathways in patients with heart failure and preserved ejection fraction. Int J Cardiol 2007.
36. Emdin M, Passino C, Prontera C, Iervasi A, Ripoli A, Masini S et al. Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure. Clin Chem Lab Med 2004;42:627-36.